Abnormal Central Motor Function C4023354
Impaired motor control originating from the brain or spinal cord. May cause movement difficulties or coordination problems. Treatment depends on the underlying neurological cause.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Sudden Weakness or Paralysis
Rapid onset of complete loss of muscle function in one or more body areas.
Seek emergency care immediately if sudden weakness or paralysis occurs, as this may indicate a stroke or other serious condition.
Breathing Difficulty
Shortness of breath or difficulty breathing due to weakness in respiratory muscles.
Seek immediate medical attention if experiencing breathing difficulties, as this can be life-threatening.
Muscle Weakness
(neurologic)Reduced strength in one or more muscle groups, making it difficult to perform everyday tasks.
Frequency: 70-80% of patients
Gait Disturbance
(neurologic)Unsteady walking pattern or difficulty maintaining balance while moving.
Frequency: 65-75% of patients
Muscle Stiffness
(neurologic)Tightness or rigidity in muscles that can limit range of motion and cause discomfort.
Frequency: 50-60% of patients
Tremor
(neurologic)Involuntary, rhythmic muscle contractions causing shaking movements, often in the hands.
Frequency: 40-50% of patients
Coordination Difficulty
(neurologic)Problems with fine motor control and maintaining balance during physical activities.
Frequency: 45-55% of patients
Fatigue
(constitutional)Persistent tiredness and lack of energy that interferes with daily activities.
Frequency: 50-60% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Motor Function Rehabilitation
Targeted physical therapy focusing on motor control, coordination, and strength training to improve central motor function through repetitive functional movements and neuromuscular re-education.
Neuromuscular Modulating Agents
Pharmacological intervention using muscle relaxants or central nervous system agents to address spasticity or motor control abnormalities when conservative measures are insufficient.
Additional treatment options
Structured Exercise Program
Regular participation in tailored exercise routines including aerobic activity, resistance training, and flexibility exercises to support motor function maintenance and neuroplasticity.
lifestyleNeurological Function Assessment
Regular neurological examinations and motor function assessments to track disease progression, treatment response, and adjust management strategies accordingly.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Central Motor Function C4023354?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
American Academy of Neurology. Practice parameter: Evaluation of distal symmetric polyneuropathy. Neurology. 2005;64(2):199-207.
Gracies JM. Pathophysiology of spastic paresis. Part I: Primary paralysis. Paresis. 2005;21(1):9-19.
Baker SN, Baker SN. The neurophysiology of movement disorders. In: Marsden CD, ed. Movement Disorders 3. Butterworth-Heinemann; 1994:28-56.
National Institute for Health and Care Excellence. Spasticity in adults: management using botulinum toxin. NICE Guideline [NG62]. 2016.
Ropper AH, Samuels MA. Adams and Victor's Principles of Neurology. 11th ed. McGraw-Hill; 2019.
Zhu G, Fan Q, Ding C, et al. Effects of repetitive transcranial magnetic stimulation on motor function in patients with stroke: A meta-analysis. PLoS One. 2022;17(8):e0273531.
American Academy of Neurology. Treatment of infantile spasms. Neurology. 2005;64(11):1834-1840.
Group PDTT. Tizanidine versus baclofen in the treatment of spasticity in multiple sclerosis patients. Acta Neurol Scand. 2007;115(5):335-339.
Wissel J, Ward AB, Erztgaard P, et al. European consensus table on spasticity management. J Rehabil Med. 2010;42(7):615-625.
Medication Comparisons
Compare medications used to treat Abnormal Central Motor Function C4023354. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy